Literature DB >> 23273718

Relation of heart-rate recovery to new onset heart failure and atrial fibrillation in patients with diabetes mellitus and preserved ejection fraction.

Kazuaki Negishi1, Sinziana Seicean, Tomoko Negishi, Teerapat Yingchoncharoen, Wael Aljaroudi, Thomas H Marwick.   

Abstract

Diabetic autonomic neuropathy is a possible link between abnormal metabolism in type 2 diabetes mellitus (T2DM) and risk for atrial fibrillation (AF) and heart failure (HF). The aim of this study was to elucidate the association between attenuated heart rate recovery (HRR) and these manifestations of myocardial dysfunction in T2DM. Nine hundred fourteen consecutive patients with T2DM (mean age 56 ± 11 years, 508 men) without diabetes mellitus complications, with negative results on stress echocardiography, were enrolled. Patients with known cardiac disease were excluded. Demographics, clinical assessment, co-morbidities, and insulin use were collected prospectively. The association of HRR with new-onset HF and AF was sought using a Cox proportional-hazards model. There were 47 events (22 HF and 25 AF) during a median follow-up period of 7.8 years. Events were associated with age, exercise capacity, HRR, and left atrial volume index but not with baseline glycosylated hemoglobin, left ventricular mass index, or standard markers of diastolic function. In sequential Cox models for the combined outcomes, the model based on clinical data (age and gender; overall chi-square = 5.5) was not significantly improved by left atrial volume index (chi-square = 8.6, p = 0.10) or maximum METs (chi-square = 8.7, p = 0.07) but was significantly improved by adding HRR (chi-square = 19.7, p = 0.004). In addition, HRR provided significant incremental prognostic value regarding the composite end point (net reclassification improvement 19.2%, p = 0.04; integrated discrimination improvement 1.58%, p = 0.004). In conclusion, the association of HRR with subsequent HF and AF, independent of and incremental to left atrial volume index and other markers of abnormal cardiac structure and function, indicates a role for autonomic neuropathy as the link between metabolic and cardiac risk in patients with T2DM.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23273718     DOI: 10.1016/j.amjcard.2012.11.028

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people.

Authors:  Celestino Sardu; Raffaele Marfella; Gaetano Santulli
Journal:  J Cardiovasc Transl Res       Date:  2014-02-06       Impact factor: 4.132

Review 2.  Catheter ablation in atrial fibrillation: is there a mortality benefit in patients with diabetes and heart failure?

Authors:  M Matta; A Saglietto; P De Salvo; A Bissolino; A Ballatore; M Anselmino
Journal:  Herz       Date:  2019-05       Impact factor: 1.443

Review 3.  Role of diabetes in heart rhythm disorders.

Authors:  Buelent Koektuerk; Murat Aksoy; Marc Horlitz; Ilkay Bozdag-Turan; Ramazan Goekmen Turan
Journal:  World J Diabetes       Date:  2016-02-10

Review 4.  Effect of antidiabetic drugs on the risk of atrial fibrillation: mechanistic insights from clinical evidence and translational studies.

Authors:  Ting-Wei Lee; Ting-I Lee; Yung-Kuo Lin; Yao-Chang Chen; Yu-Hsun Kao; Yi-Jen Chen
Journal:  Cell Mol Life Sci       Date:  2020-09-23       Impact factor: 9.261

5.  Combinational Biomarkers for Atrial Fibrillation Derived from Atrial Appendage and Plasma Metabolomics Analysis.

Authors:  Songqing Lai; Xiumeng Hua; Ran Gao; Liang Zeng; Jiangping Song; Jichun Liu; Jing Zhang
Journal:  Sci Rep       Date:  2018-11-16       Impact factor: 4.379

Review 6.  Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic Outcomes.

Authors:  Laurel A Grisanti
Journal:  Front Physiol       Date:  2018-11-26       Impact factor: 4.566

Review 7.  The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights.

Authors:  Loryn J Bohne; Dustin Johnson; Robert A Rose; Stephen B Wilton; Anne M Gillis
Journal:  Front Physiol       Date:  2019-02-26       Impact factor: 4.566

8.  Comprehensive metabolomic characterization of atrial fibrillation.

Authors:  Chengcan Lu; Chunyan Liu; Di Mei; Mengjie Yu; Jian Bai; Xue Bao; Min Wang; Kejia Fu; Xin Yi; Weihong Ge; Jizhong Shen; Yuzhu Peng; Wei Xu
Journal:  Front Cardiovasc Med       Date:  2022-08-08

Review 9.  A New Hope: Sodium-Glucose Cotransporter-2 Inhibition to Prevent Atrial Fibrillation.

Authors:  Nikolaos Karamichalakis; Vasileios Kolovos; Ioannis Paraskevaidis; Elias Tsougos
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-26

10.  Insulin resistance is independently associated with cardiovascular autonomic neuropathy in type 2 diabetes.

Authors:  Yingshan Liu; Yu Peng; Jing Jin; Yanshan Chen; Chuna Chen; Zhenguo Chen; Haishan Huang; Lingling Xu
Journal:  J Diabetes Investig       Date:  2021-02-15       Impact factor: 4.232

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.